In January 2019, the US Food & Drug Administration (FDA) made an unprecedented call for an OTC Naloxone product. Why? Because every 8 minutes someone in America is dying from an opioid overdose –  and the antidote Naloxone is not at hand to save them.

But it could be.

Pocket Naloxone is answering that call for OTC Naloxone to remove the critical barriers that exist:

• Stigma. Even if someone can afford to pay the current high retail price, walking up to the pharmacy counter and asking for it is difficult.
• Pharmacist Confusion. Many pharmacists are still confused whether they could or could not dispense Naloxone without a prescription under State standing orders. Often the supervisor is called and a prolonged discussion is needed.
• Price. Critical to have low-cost affordable Naloxone for consumers and institutions.

More than 35 million people (yes, that’s 10 percent of the population) are at risk of an opioid overdose and desperately need an accessible, affordable antidote. There is an urgent need, and we are proud to play a role in addressing this aspect of the opioid crisis to limit needless overdose deaths.